Bank of America’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,737
| Closed | -$27.9K | – | 6672 |
|
|
2025
Q4 | $27.9K | Sell |
10,737
-2,118
| -16% | -$4.26K | ﹤0.01% | 5982 |
|
|
2025
Q3 | $22.6K | Buy |
12,855
+2,345
| +22% | +$3.75K | ﹤0.01% | 7046 |
|
|
2025
Q2 | $14.6K | Sell |
10,510
-3,230
| -24% | -$4.21K | ﹤0.01% | 7115 |
|
|
2025
Q1 | $13.5K | Buy |
13,740
+1,990
| +17% | +$2.4K | ﹤0.01% | 7056 |
|
|
2024
Q4 | $15.4K | Sell |
11,750
-909
| -7% | -$2.71K | ﹤0.01% | 6894 |
|
|
2024
Q3 | $43.5K | Buy |
12,659
+2,405
| +23% | +$7.92K | ﹤0.01% | 6580 |
|
|
2024
Q2 | $33.8K | Sell |
10,254
-12,565
| -55% | -$44.8K | ﹤0.01% | 6610 |
|
|
2024
Q1 | $107K | Buy |
22,819
+1,194
| +6% | +$7.65K | ﹤0.01% | 6211 |
|
|
2023
Q4 | $158K | Buy |
21,625
+13,657
| +171% | +$76.4K | ﹤0.01% | 6198 |
|
|
2023
Q3 | $96.3K | Sell |
7,968
-1,050
| -12% | -$10.8K | ﹤0.01% | 6266 |
|
|
2023
Q2 | $95.4K | Sell |
9,018
-8,436
| -48% | -$86.9K | ﹤0.01% | 6223 |
|
|
2023
Q1 | $172K | Sell |
17,454
-243,432
| -93% | -$2.79M | ﹤0.01% | 6003 |
|
|
2022
Q4 | $3.84M | Buy |
260,886
+247,926
| +1,913% | +$3.71M | ﹤0.01% | 3645 |
|
|
2022
Q3 | $158K | Buy |
12,960
+1,770
| +16% | +$22.8K | ﹤0.01% | 6116 |
|
|
2022
Q2 | $157K | Sell |
11,190
-20,231
| -64% | -$238K | ﹤0.01% | 6250 |
|
|
2022
Q1 | $448K | Sell |
31,421
-452
| -1% | -$6.7K | ﹤0.01% | 5916 |
|
|
2021
Q4 | $672K | Buy |
31,873
+8,459
| +36% | +$199K | ﹤0.01% | 5618 |
|
|
2021
Q3 | $615K | Buy |
23,414
+18,570
| +383% | +$600K | ﹤0.01% | 5483 |
|
|
2021
Q2 | $151K | Sell |
4,844
-15,451
| -76% | -$506K | ﹤0.01% | 6273 |
|
|
2021
Q1 | $622K | Buy |
20,295
+19,356
| +2,061% | +$657K | ﹤0.01% | 5196 |
|
|
2020
Q4 | $32K | Buy |
+939
| New | +$28.1K | ﹤0.01% | 6473 |
|
Bank of America's RPTX Position: Q1 2026 in Review
Bank of America sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 10,737 shares — an estimated $27.9K sold.
Bank of America first reported a position in RPTX in Q4 2020 and held it in 21 quarters. The position peaked at $3.84M in Q4 2022. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Bank of America reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 10,737 Repare Therapeutics shares in Q1 2026, an estimated $27.9K.
- Bank of America first reported a position in Repare Therapeutics in Q4 2020 and held it in 21 quarters.
- Bank of America's Repare Therapeutics position peaked at $3.84M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.